Literature DB >> 16694724

IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE.

M Finland1, W C Spring, F C Lowell.   

Abstract

Entities:  

Year:  1940        PMID： 16694724      PMCID： PMC434952          DOI： 10.1172/JCI101110

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  ANTIBODY RESPONSE TO INFECTIONS WITH TYPE III AND THE RELATED TYPE VIII PNEUMOCOCCUS.

Authors:  M Finland; A W Winkler
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

2.  IMMUNOLOGICAL STUDIES IN PATIENTS WITH PNEUMOCOCCUS TYPE III PNEUMONIA TREATED WITH SUL-FANILAMIDE AND SERUM.

Authors:  M Finland; J W Brown
Journal:  J Clin Invest       Date:  1939-05       Impact factor: 14.808

3.  ANTIBODY RESPONSE TO INFECTIONS WITH TYPE II AND THE RELATED TYPE V PNEUMOCOCCUS.

Authors:  M Finland; A W Winkler
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

4.  STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI.

Authors:  W C Spring; F C Lowell; M Finland
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

5.  BACTERICIDAL ACTION OF SODIUM SULFAPYRIDINE AND OF A GLUCOSE-SULFAPYRIDINE SOLUTION IN HUMAN BLOOD.

Authors:  F C Lowell; W C Spring; M Finland
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808
  5 in total
  13 in total

1.  SPECIFIC ANTIPNEUMOCOCCAL IMMUNITY IN RELATION TO THE CHEMOTHERAPY OF PNEUMONIA.

Authors:  W S Tillett; M J Cambier; H Dunn
Journal:  J Clin Invest       Date:  1942-09       Impact factor: 14.808

2.  COMPLEMENT ACTIVITY IN PNEUMONIA.

Authors:  D D Rutstein; W H Walker
Journal:  J Clin Invest       Date:  1942-05       Impact factor: 14.808

3.  THE IMMUNE RESPONSE OF HUMAN BEINGS TO BRIEF INFECTIONS WITH PNEUMOCOCCUS.

Authors:  M Heidelberger; D G Anderson
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

4.  ANTIBODY FORMATION IN CASES OF LOBAR PNEUMONIA TREATED WITH SULFATHIAZOLE.

Authors:  Y Kneeland; B Mulliken
Journal:  J Clin Invest       Date:  1940-09       Impact factor: 14.808

5.  STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI.

Authors:  W C Spring; F C Lowell; M Finland
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

6.  Immunological studies of pneumococcal pneumonia in patients treated with penicillin.

Authors:  W S JORDAN; G F BADGER; J H DINGLE
Journal:  J Clin Invest       Date:  1950-02       Impact factor: 14.808

Review 7.  Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health.

Authors:  George H Talbot; John H Powers; Thomas R Fleming; Judith A Siuciak; John Bradley; Helen Boucher
Journal:  Clin Infect Dis       Date:  2012-06-28       Impact factor: 9.079

8.  Complement levels in pneumococcal pneumonia.

Authors:  J D Coonrod; B Rylko-Bauer
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

9.  BACTERICIDAL ACTION OF SODIUM SULFAPYRIDINE AND OF A GLUCOSE-SULFAPYRIDINE SOLUTION IN HUMAN BLOOD.

Authors:  F C Lowell; W C Spring; M Finland
Journal:  J Clin Invest       Date:  1940-01       Impact factor: 14.808

10.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.